WELL vs DOC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
WELL · Welltower$245.01 ▼ 0.17%
DOC · Healthpeak Properties$20.26 ▲ 0.70%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- WELL +29.6%
- DOC +21.6%
Head to head
| Metric | WELL | DOC |
|---|---|---|
| Price | $245.01 | $20.26 |
| Change today | ▼ 0.17% | ▲ 0.70% |
| Market cap | $179.74B | $13.97B |
| Return, 3 months | +4.6% | -2.1% |
| Return, year to date | +33.4% | +32.2% |
| Return, 1 year | +30.7% | +20.7% |
| P/E (TTM) | 107.0 | 37.5 |
| P/B | 3.7 | 1.8 |
| P/E percentile vs own 5y | 32nd | 28th |
| Dividend yield | 1.25% | 6.02% |
| Revenue growth (YoY, latest qtr) | +40.5% | +11.1% |
| Net profit growth (YoY) | +47.0% | +62.1% |
| Gross margin | 38.6% | 58.1% |
| Operating margin | 6.2% | 17.8% |
| Net margin | 12.2% | 8.2% |
| Return on equity | 3.8% | 3.1% |
| Analyst target vs. price | +7.0% | +8.1% |
| Analyst buy share | 92% | 15% |
| RSI (14) | 61 | 62 |
| 30-day volatility | 27.1% | 28.6% |
| Max drawdown, 1 year | -12.6% | -18.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- WELL is the largest of the group by market value.
- WELL has returned the most over the past year.
- DOC carries the lowest trailing P/E.
- DOC pays the highest dividend yield.
- WELL is growing revenue fastest.
- WELL keeps the most profit per dollar of sales.
- WELL has been the calmest stock over the last 30 days.